Form 4 for IMUX IMMUNIC, INC.
Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-05 · accession 0001193805-25-000839 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-09 | 2025-06-05 | IMUX | Tardio Jason | Pres, COO | P - Purchase | $0.79 | +12.5K | 12.5K | New | +$9,884 |
| D | 2025-06-09 | 2025-06-05 | IMUX | Tardio Jason | Pres, COO | A - Grant | $0.00 | +595.0K | 595.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-05 | P | A | 12,512 | $0.79 | 12,512 | D | — | — | |
| 2 | Derivative | Stock Option | 2025-06-05 | A | A | 595,000 | $0.00 | 595,000 | D | $0.77 · — to 2035-06-05 | 595,000 Common Stock | (F1) 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months. |